Kiriazy
Minya, Elminya, 2422998, Egypt
Completed
NCT Number: NCT07519785
Prognostic Value of PLR On Cardiovascular Complications in Chronic Hemodialysis Patients
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries as these complications are common and well-known causes of morbidity and mortality in chronic hemodialysis patients
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients undergoing hemodialysis for more than 3 months who agreed to be included in the study
Exclusion criteria
- We are going to exclude patients who have:
- Younger than 18 year- old or Older than 75 year-old,
- Patients with positive serum marker of anti-hepatitis C virus (anti-HCV), hepatitis B surface antigen (HBsAg) and human immunodeficiency virus (HIV).
- Alcohol or illicit drug abusers.
- Inflammatory state due to infection,
Treatment and study plan
Primary outcomes
-
To evaluate the association between platelet-to-lymphocyte ratio and cardiovascular complications in patients on chronic maintenance hemodialysis.
Time frame: 6 months
Primary Outcome Association between PLR and cardiovascular complications in chronic hemodialysis patients.
Secondary Outcomes optimal PLR cutoff for cardiovascular complication prediction relation of PLR to individual cardiovascular diagnoses relation of PLR to cardiovascular hospitalization relation of PLR to cardiovascular mortality
Sponsors and collaborators
Lead sponsor
Minia University
Other
Registry information
Official study title
Prognostic Value of the Platelet to Lymphocyte Ratio on Cardiovascular Complications in Chronic Hemodialysis Patients
Important dates
- Study start
- 2024
- Primary completion
- 2024
- Study completion
- 2024
- First posted
- Apr 9, 2026
- Registry last updated
- Apr 13, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.